{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T08:17:57Z","timestamp":1648714677516},"reference-count":28,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revista Cl\u00ednica Espa\u00f1ola"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1157\/13093465","type":"journal-article","created":{"date-parts":[[2006,10,26]],"date-time":"2006-10-26T08:05:42Z","timestamp":1161849942000},"page":"417-421","source":"Crossref","is-referenced-by-count":11,"title":["Objetivos del tratamiento hipolipemiante en pacientes con alto riesgo y muy alto riesgo cardiovascular: \u00bfun reto posible?"],"prefix":"10.1016","volume":"206","author":[{"given":"A.","family":"G\u00f3mez-Belda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Rodilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.A.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Serra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1157\/13093465_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-74-1-1","article-title":"Serum cholesterol, lipoproteins and the risk of coronary heart disease: the Framingham study","volume":"74","author":"Kannel","year":"1971","journal-title":"Ann Intern Med"},{"key":"10.1157\/13093465_bib2","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1001\/jama.1982.03330120023025","article-title":"Multiple risk Factor ntervention Trial: risk factor changes and mortality results","volume":"248","year":"1982","journal-title":"JAMA"},{"key":"10.1157\/13093465_bib3","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)","volume":"334","year":"1994","journal-title":"Lancet"},{"key":"10.1157\/13093465_bib4","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","article-title":"The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels","volume":"335","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1157\/13093465_bib5","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199811053391902","article-title":"Prevention of cardiovascular events with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels","volume":"339","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1157\/13093465_bib6","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","article-title":"Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia","volume":"333","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1157\/13093465_bib7","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1001\/jama.279.20.1615","article-title":"Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS\/texCAPS","volume":"279","author":"Downs","year":"1998","journal-title":"JAMA"},{"key":"10.1157\/13093465_bib8","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1157\/13093465_bib9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"10.1157\/13093465_bib10","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1157\/13093465_bib11","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jacc.2004.07.001","article-title":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines","volume":"44","author":"Grundy","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1157\/13093465_bib12","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0025-7753(03)74008-1","article-title":"Uso cl\u00ednico de las estatinas y objetivos terap\u00e9uticos en relaci\u00f3n con el riesgo cardiovascular","volume":"121","author":"G\u00f3mez Belda","year":"2003","journal-title":"Med Clin (Barc)"},{"issue":"Suppl 3","key":"10.1157\/13093465_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00019053-200422003-00002","article-title":"Current lipid management and low cholesterol goal attainment in common daily practice in Spain. The REALITY Study","volume":"22","author":"Garc\u00eda Ruiz","year":"2004","journal-title":"Pharmacoeconomics"},{"issue":"2","key":"10.1157\/13093465_bib14","first-page":"44","article-title":"Integral control of risk factors in patients of high and very high cardiovascular risk in Spain. CIFARC Project","volume":"124","author":"De la Pena Fern\u00e1ndez","year":"2005","journal-title":"Med Clin (Barc)"},{"key":"10.1157\/13093465_bib15","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/bmj.293.6547.611","article-title":"British Hypertension Society. Recommendations on blood pressure measurement","volume":"293","author":"Petrie","year":"1986","journal-title":"Br Med J"},{"key":"10.1157\/13093465_bib16","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoproteins cholesterol in plasma without the use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"10.1157\/13093465_bib17","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.2337\/diacare.20.7.1183","article-title":"Report of the Expert Committee on the diagnosis and Classification of Diabetes Mellitus","volume":"20","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1157\/13093465_bib18","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S0014-2565(00)70705-3","article-title":"Control de la colesterolemia en Espa\u00f1a, 2000: un instrumento para la prevenci\u00f3n cardiovascular","volume":"200","author":"Plaza P\u00e9rez","year":"2000","journal-title":"Rev Clin Esp"},{"key":"10.1157\/13093465_bib19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1161\/01.CIR.101.2.207","article-title":"Current perspectives on statins","volume":"101","author":"Maron","year":"2000","journal-title":"Circulation"},{"key":"10.1157\/13093465_bib20","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ahj.2004.11.023","article-title":"Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: the Vytorin Versus Atorvastatin (VYVA) Study","volume":"149","author":"Ballantyne","year":"2005","journal-title":"Am Heart J"},{"key":"10.1157\/13093465_bib21","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.2337\/diacare.28.5.1029","article-title":"The Challenge Of Achieving National Cholesterol Goals In Patients With Diabetes","volume":"28","author":"Kennedy","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1157\/13093465_bib22","first-page":"601","article-title":"Importancia del s\u00edndrome metab\u00f3lico en el control de la presi\u00f3n arterial y de la dislipemia","volume":"123","author":"Rodilla","year":"2004","journal-title":"Med Clin (Barc)"},{"key":"10.1157\/13093465_bib23","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0002-9149(03)00474-0","article-title":"Effectiveness of statins titration on low-density lipoprotein cholesterol goal attainment in patients at high risk of atherogenic events","volume":"92","author":"Foley","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1157\/13093465_bib24","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1157\/13070853","article-title":"Planificaci\u00f3n de la hipercolesterolemia orientada a la obtenci\u00f3n de objetivos","volume":"124","author":"Massana","year":"2005","journal-title":"Med Clin (Barc)"},{"key":"10.1157\/13093465_bib25","doi-asserted-by":"crossref","first-page":"587","DOI":"10.4065\/80.5.587","article-title":"A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP-ATP III goals for LDL cholesterol in hypercholesterolemic patients: the ezetimibe add-on to satin for effectiveness (EASE) trial","volume":"80","author":"Pearson","year":"2005","journal-title":"Mayo Clin Proc"},{"key":"10.1157\/13093465_bib26","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1157\/13076400","article-title":"Selective cholesterol absorption inhibition as a new prospect in treatment of hypercholesterolemia","volume":"125","author":"Lima","year":"2005","journal-title":"Med Clin (Barc)"},{"key":"10.1157\/13093465_bib27","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1001\/jama.282.15.1458","article-title":"Why don\u2019t physicians follow clinical practice guidelines?","volume":"282","author":"Cabana","year":"1999","journal-title":"JAMA"},{"key":"10.1157\/13093465_bib28","first-page":"57","article-title":"Eficacia cl\u00ednica de la ezemtimiba y objetivos terap\u00e9uticos de colesterol LDL","volume":"18","author":"Pascual","year":"2006","journal-title":"Clin Invest Ateroesclerosis"}],"container-title":["Revista Cl\u00ednica Espa\u00f1ola"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001425650672848X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001425650672848X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,18]],"date-time":"2020-04-18T19:41:51Z","timestamp":1587238911000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001425650672848X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["S001425650672848X"],"URL":"https:\/\/doi.org\/10.1157\/13093465","relation":{},"ISSN":["0014-2565"],"issn-type":[{"value":"0014-2565","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10]]}}}